ACA

Avoro Capital Advisors Portfolio holdings

AUM $5.71B
1-Year Return 11.37%
This Quarter Return
+7.99%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$6.86B
AUM Growth
-$650M
Cap. Flow
-$827M
Cap. Flow %
-12.06%
Top 10 Hldgs %
69.62%
Holding
42
New
–
Increased
10
Reduced
8
Closed
6

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$118M
2
PCVX icon
Vaxcyte
PCVX
$68.6M
3
KRYS icon
Krystal Biotech
KRYS
$34.4M
4
KYMR icon
Kymera Therapeutics
KYMR
$28.9M
5
DYN icon
Dyne Therapeutics
DYN
$19.2M

Top Sells

1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$308M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$281M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
$177M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
$97.2M
5
IOVA icon
Iovance Biotherapeutics
IOVA
$70M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RARE icon
26
Ultragenyx Pharmaceutical
RARE
$3.07B
$46.1M 0.67%
830,000
– –
AUTL
27
Autolus Therapeutics
AUTL
$389M
$44.8M 0.65%
12,345,678
– –
IOVA icon
28
Iovance Biotherapeutics
IOVA
$901M
$39.8M 0.58%
4,240,000
-7,460,000
-64% -$70M
TSHA icon
29
Taysha Gene Therapies
TSHA
$917M
$37.5M 0.55%
18,650,000
– –
GLUE icon
30
Monte Rosa Therapeutics
GLUE
$305M
$30.7M 0.45%
5,790,236
+1,255,236
+28% +$6.65M
CGON icon
31
CG Oncology
CGON
$2.52B
$26.4M 0.39%
700,000
– –
DYN icon
32
Dyne Therapeutics
DYN
$2.02B
$23.3M 0.34%
650,000
+534,249
+462% +$19.2M
SYRE icon
33
Spyre Therapeutics
SYRE
$1.03B
$17.6M 0.26%
598,600
-1,240,538
-67% -$36.5M
WHWK
34
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
$5.87M 0.09%
2,849,402
– –
NGNE icon
35
Neurogene
NGNE
$285M
$924K 0.01%
22,029
– –
ALNY icon
36
Alnylam Pharmaceuticals
ALNY
$59.2B
– –
-400,000
Closed -$97.2M
ADVM icon
37
Adverum Biotechnologies
ADVM
$73.9M
– –
-416,666
Closed -$2.86M
BCYC
38
Bicycle Therapeutics
BCYC
$496M
– –
-700,000
Closed -$14.2M
INSM icon
39
Insmed
INSM
$30.7B
– –
0
– –
VRCA icon
40
Verrica Pharmaceuticals
VRCA
$48.2M
– –
-400,000
Closed -$29.2M
XBI icon
41
SPDR S&P Biotech ETF
XBI
$5.39B
– –
-3,035,000
Closed -$281M
CERE
42
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-7,539,547
Closed -$308M
1
2